HEADER VIRUS/VIRAL PROTEIN/DNA 20-FEB-06 2G3L TITLE THEORETICAL MODEL OF TETRAMER OF HIV-1 INTEGRASE WITH TWO TITLE 2 VIRAL LTR ENDS COMPND MOL_ID: 1; COMPND 2 MOLECULE: GAG-POL POLYPROTEIN (PR160GAG-POL) INTEGRASE COMPND 3 (IN); COMPND 4 CHAIN: A, B, C, D; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: TGTGGAAAATCTCTAGCA; COMPND 7 CHAIN: E, G; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: ACTGCTAGAGATTTTCCACA; COMPND 11 CHAIN: F, H; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1; SOURCE 3 ORGANISM_COMMON: VIRUS; SOURCE 4 MOL_ID: 2; SOURCE 5 SYNTHETIC: YES; SOURCE 6 MOL_ID: 3; SOURCE 7 SYNTHETIC: YES KEYWDS PROTEIN-DNA COMPLEX EXPDTA THEORETICAL MODEL AUTHOR A.CHEN,I.T.WEBER,R.W.HARRISON,J.LEIS REVDAT 1 28-MAR-06 2G3L 0 JRNL AUTH A.CHEN,I.T.WEBER,R.W.HARRISON,J.LEIS JRNL TITL IDENTIFICATION OF AMINO ACIDS IN HIV-1 AND AVIAN JRNL TITL 2 SARCOMA VIRUS INTEGRASE SUBSITES REQUIRED FOR JRNL TITL 3 SPECIFIC RECOGNITION OF THE LONG TERMINAL REPEAT JRNL TITL 4 ENDS JRNL REF J.BIOL.CHEM. V. 281 4173 2006 JRNL REFN ASTM JBCHA3 US ISSN 0021-9258 REMARK 1 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : AMMP REMARK 3 AUTHORS : R.W. HARRISON REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: STRUCTURAL MODEL FOR HIV-1 IN WITH REMARK 3 BOUND LTR DNA- THE INITIAL MODEL FOR THE FULL-LENGTH 3-DOMAIN REMARK 3 INTEGRASE (IN) STRUCTURE WAS CONSTRUCTED BY COMBINING THE REMARK 3 SEPARATE 2-DOMAIN CRYSTAL STRUCTURES OF THE N-TERMINAL DOMAIN REMARK 3 AND CATALYTIC CORE (1K6Y) AND THE CATALYTIC CORE AND C- REMARK 3 TERMINAL DOMAIN (1EX4). THE 1K6Y TETRAMER BUILT FROM CRYSTAL REMARK 3 LATTICE CONTACTS WAS THE BASIS FOR FORMING THE TETRAMER OF REMARK 3 FULL-LENGTH IN. THE ZINC COORDINATION COMPLEX WAS COVALENTLY REMARK 3 MODELED USING 2.25 BOND LENGTH RESTRAINTS TO THE COORDINATING REMARK 3 HISTIDINES. RESIDUES 271-288 AT THE C-TERMINUS ARE DISORDERED REMARK 3 AND WERE OMITTED FROM THE MODEL. RESIDUES 47-55 AND 140-148 REMARK 3 ARE DISORDERED IN THE N-TERMINAL 2-DOMAIN STRUCTURE. THE REMARK 3 MISSING LOOPS WERE PRODUCED BY OBTAINING INITIAL C* -C* REMARK 3 DISTANCES FROM A DYNAMIC PROGRAMMING SEARCH OF OVERLAPPING 30- REMARK 3 MERS GENERATED FROM THE WHOLE PDB DATABASE. THE PROGRAM AMMP REMARK 3 (HARRISON, 1993) WAS USED WITH THE CURRENT ALL-ATOM SP4 REMARK 3 POTENTIAL SET (WEBER & HARRISON, 1996, 1997). THE CHARGE REMARK 3 GENERATION PARAMETERS WERE TAKEN FROM BAGOSSI ET AL. (1999). REMARK 3 THE NEW ATOMS WERE BUILT USING THE KOHONEN AND ANALYTIC MODEL REMARK 3 BUILDING FEATURES OF AMMP (HARRISON, 1999), AND MINIMIZED WITH REMARK 3 CONJUGATE GRADIENTS. THE AMORTIZED FAST MULTIPOLE ALGORITHM IN REMARK 3 AMMP WAS USED FOR THE LONG-RANGE TERMS IN THE NON-BONDED AND REMARK 3 ELECTROSTATIC POTENTIALS SO THAT NO-CUTOFF RADIUS WAS REMARK 3 EMPLOYED. THE MODEL CONTAINED 4 POTASSIUM AND 4 PHOSPHATE IONS REMARK 3 FROM THE CRYSTAL STRUCTURES. THE TETRAMER MODEL WAS SOLVATED REMARK 3 IN 16,195 WATER MOLECULES. THIS SOLVATED INTEGRASE WAS REMARK 3 SUBJECTED TO MOLECULAR DYNAMICS SIMULATION FOR 1.0 NS ON A 1 REMARK 3 GHZ LINUX PC. FRAMES WERE SAVED EVERY 1PS. DURING THE REMARK 3 SIMULATIONS THE C-TERMINAL DOMAINS ROTATED INTO A DIFFERENT REMARK 3 CONFORMATION AND FORMED A POTENTIAL BINDING SITE FOR DNA. THE REMARK 3 INITIAL MODEL FOR VIRAL DNA WAS TAKEN FROM THE CRYSTAL REMARK 3 STRUCTURE OF 1K61, WHICH CONTAINED 20 BASE PAIRS OF B-DNA. THE REMARK 3 DNA WAS CONVERTED TO THE HIV U5 SEQUENCE USING AMMP TO REMARK 3 GENERATE NEW ATOMIC POSITIONS WITH AN ANALYTIC COORDINATE REMARK 3 GENERATOR (HARRISON, 1999) FOLLOWED BY CONJUGATE GRADIENTS REMARK 3 MINIMIZATION FOR EACH SUBSTITUTED BASE PAIR. THEN THE ENTIRE REMARK 3 DNA MOLECULE WAS MINIMIZED USING CONJUGATE GRADIENTS WITH ALL REMARK 3 NON-BONDED AND GEOMETRIC TERMS. THE DNA WAS POSITIONED REMARK 3 APPROXIMATELY USING THE DNA AT THE CATALYTIC SITE OF TN5 REMARK 3 TRANSPOSASE AS A GUIDE TO PLACE THE PROCESSED 3 OH AT THE REMARK 3 CATALYTIC SITE OF IN. THE TWO PROCESSED NUCLEOTIDES GT WERE REMARK 3 REMOVED FROM THE 3 END. A MAGNESIUM ION WAS PLACED BETWEEN THE REMARK 3 3 OH, AND THE SIDE CHAINS OF ASP 64 AND ASP 116 AT THE REMARK 3 CATALYTIC SITE OF EACH SUBUNIT. THE DNA WAS ROTATED AND REMARK 3 TRANSLATED INTO THE GROOVE FORMED BETWEEN THE CATALYTIC DOMAIN REMARK 3 OF SUBUNIT B AND N- AND C-TERMINAL DOMAINS OF SUBUNIT D REMARK 3 APPROXIMATELY USING O (JONES ET AL., 1991). THE FIT TO IN WAS REMARK 3 OPTIMIZED USING THE GDOCK ROUTINE OF AMMP WITH HARMONIC REMARK 3 RESTRAINTS TO ATOMIC POSITIONS FOR CRITICAL ATOMS (TETHERS) REMARK 3 AND RESTRAINTS ON THE DNA INTERATOMIC DISTANCES, FOLLOWED BY REMARK 3 CONJUGATE GRADIENTS MINIMIZATION. THE GDOCK ROUTINE USES A REMARK 3 GENETIC ALGORITHM TO SEARCH ROTATIONAL AND TRANSLATIONAL SPACE REMARK 3 WHERE THE ROTATIONAL COMPONENTS ARE REPRESENTED WITH UNIT REMARK 3 QUATERNIONS. THE USE OF UNIT QUATERNIONS INSTEAD OF ORTHOGONAL REMARK 3 ROTATION MATRICES AVOIDS ARTIFICIAL SINGULARITIES IN THE REMARK 3 SEARCH SPACE AND GREATLY ENHANCES THE CONVERGENCE OF THE REMARK 3 ALGORITHM. THE TWO UNPAIRED NUCLEOTIDES 1-2 WERE MOVED OUT OF REMARK 3 THE B-FORM USING TORSION SEARCHES TO ELIMINATE COLLISION WITH REMARK 3 THE PROTEIN. THE 3 OH WAS RESTRAINED TO COORDINATE WITH THE MG REMARK 3 ION AT THE CATALYTIC SITE. ONCE THE FIRST DNA WAS PLACED IN REMARK 3 THE GROOVE, THE SECOND LTR END WAS PLACED BY SYMMETRY BETWEEN REMARK 3 THE CATALYTIC DOMAINS OF SUBUNIT D AND THE N- AND C-TERMINAL REMARK 3 DOMAINS OF SUBUNIT B, FOLLOWED BY ALTERNATING RIGID BODY REMARK 3 MOVEMENTS OF THE LTR AND C-TERMINAL DOMAIN USING GDOCK TO REMARK 3 OVERCOME COLLISIONS SINCE THE TETRAMER MODEL IS NOT COMPLETELY REMARK 3 SYMMETRIC. FINALLY, THE COMPLEX WAS MINIMIZED BY CONJUGATE REMARK 3 GRADIENTS TO ENSURE GOOD NON-BONDED INTERACTIONS. HARRISON, R. REMARK 3 W. (1993) J. COMP. CHEM. 14:1112-1122. WEBER, I. T. AND REMARK 3 HARRISON, R. W. (1996) PROTEIN ENG. 9:679-690. WEBER, I. T. REMARK 3 AND HARRISON, R. W. (1997) PROTEIN SCI. 11:2365-2374. BAGOSSI, REMARK 3 P., ZAHUCZKY, G., TOZSER, J., WEBER, I. T. AND HARRISON, R. W. REMARK 3 (1999) J. MOL. MODEL 5: 143-152. HARRISON, R. W. (1999) J. REMARK 3 MATH.CHEM. 26:125-137. JONES, T. A., ZOU, J. Y., COWAN, S. W., REMARK 3 AND KJELDGAARD, M. (1991) ACTA CRYST. A47: 110-119. REMARK 4 REMARK 4 2G3L COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-FEB-2006. REMARK 100 THE RCSB ID CODE IS RCSB036645. REMARK 103 REMARK 103 THERE ARE NON-WATSON-CRICK HYDROGEN BONDS BETWEEN THE REMARK 103 FOLLOWING ATOMS: REMARK 103 N6 A E 2006 AND O4 T F 2034 REMARK 103 N1 A E 2006 AND N3 T F 2035 REMARK 103 N1 A E 2007 AND N3 T F 2034 REMARK 103 N1 A E 2009 AND N3 T F 2032 REMARK 103 N3 T E 2012 AND N1 A F 2029 REMARK 103 N3 T E 2014 AND N1 A F 2027 REMARK 103 N1 A E 2015 AND N3 T F 2026 REMARK 103 N1 G E 2016 AND N3 C F 2025 REMARK 103 N3 T G 2103 AND N1 A H 2138 REMARK 103 O6 G G 2104 AND N4 C H 2136 REMARK 103 N1 G G 2104 AND O2 C H 2137 REMARK 103 N1 A G 2106 AND N3 T H 2135 REMARK 103 N1 A G 2107 AND N3 T H 2134 REMARK 103 N1 A G 2108 AND N3 T H 2133 REMARK 103 N1 A G 2109 AND N3 T H 2132 REMARK 103 N3 T G 2112 AND N1 A H 2129 REMARK 103 N3 T G 2114 AND N1 A H 2127 REMARK 103 N1 A G 2115 AND N3 T H 2126 REMARK 103 N1 G G 2116 AND N3 C H 2125 REMARK 105 REMARK 105 THE PROTEIN DATA BANK HAS ADOPTED THE SACCHARIDE CHEMISTS REMARK 105 NOMENCLATURE FOR ATOMS OF THE DEOXYRIBOSE/RIBOSE MOIETY REMARK 105 RATHER THAN THAT OF THE NUCLEOSIDE CHEMISTS. THE RING REMARK 105 OXYGEN ATOM IS LABELLED O4* INSTEAD OF O1*. REMARK 220 REMARK 220 EXPERIMENTAL DETAILS REMARK 220 EXPERIMENT TYPE : THEORETICAL MODELLING REMARK 220 REMARK 220 REMARK: THIS TETRAMER INTEGRASE MODEL WAS PRODUCED FROM A 1 REMARK 220 NANOSECOND MOLECULAR DYNAMICS SIMULATION (AMMP) STARTING REMARK 220 FROM PDB STRUCTURE ID 1K6Y AND 1EX4. THE DNA MODEL WAS REMARK 220 PRODUCED FROM AMMP STARTING FROM PDB STRUCTURE ID 1K61. REMARK 220 STRUCTURAL MODEL FOR HIV-1 IN WITH BOUND LTR DNA- THE REMARK 220 INITIAL MODEL FOR THE FULL-LENGTH 3-DOMAIN INTEGRASE REMARK 220 (IN) STRUCTURE WAS CONSTRUCTED BY COMBINING THE SEPARATE REMARK 220 2-DOMAIN CRYSTAL STRUCTURES OF THE N-TERMINAL DOMAIN AND REMARK 220 CATALYTIC CORE (1K6Y) AND THE CATALYTIC CORE AND C- REMARK 220 TERMINAL DOMAIN (1EX4). THE 1K6Y TETRAMER BUILT FROM REMARK 220 CRYSTAL LATTICE CONTACTS WAS THE BASIS FOR FORMING THE REMARK 220 TETRAMER OF FULL-LENGTH IN. THE ZINC COORDINATION REMARK 220 COMPLEX WAS COVALENTLY MODELED USING 2.25 BOND LENGTH REMARK 220 RESTRAINTS TO THE COORDINATING HISTIDINES. RESIDUES 271- REMARK 220 288 AT THE C-TERMINUS ARE DISORDERED AND WERE OMITTED REMARK 220 FROM THE MODEL. RESIDUES 47-55 AND 140-148 ARE REMARK 220 DISORDERED IN THE N-TERMINAL 2-DOMAIN STRUCTURE. THE REMARK 220 MISSING LOOPS WERE PRODUCED BY OBTAINING INITIAL C* -C* REMARK 220 DISTANCES FROM A DYNAMIC PROGRAMMING SEARCH OF REMARK 220 OVERLAPPING 30-MERS GENERATED FROM THE WHOLE PDB REMARK 220 DATABASE. THE PROGRAM AMMP (HARRISON, 1993) WAS USED REMARK 220 WITH THE CURRENT ALL-ATOM SP4 POTENTIAL SET (WEBER & REMARK 220 HARRISON, 1996, 1997). THE CHARGE GENERATION PARAMETERS REMARK 220 WERE TAKEN FROM BAGOSSI ET AL. (1999). THE NEW ATOMS REMARK 220 WERE BUILT USING THE KOHONEN AND ANALYTIC MODEL BUILDING REMARK 220 FEATURES OF AMMP (HARRISON, 1999), AND MINIMIZED WITH REMARK 220 CONJUGATE GRADIENTS. THE AMORTIZED FAST MULTIPOLE REMARK 220 ALGORITHM IN AMMP WAS USED FOR THE LONG-RANGE TERMS IN REMARK 220 THE NON-BONDED AND ELECTROSTATIC POTENTIALS SO THAT NO- REMARK 220 CUTOFF RADIUS WAS EMPLOYED. THE MODEL CONTAINED 4 REMARK 220 POTASSIUM AND 4 PHOSPHATE IONS FROM THE CRYSTAL REMARK 220 STRUCTURES. THE TETRAMER MODEL WAS SOLVATED IN 16,195 REMARK 220 WATER MOLECULES. THIS SOLVATED INTEGRASE WAS SUBJECTED REMARK 220 TO MOLECULAR DYNAMICS SIMULATION FOR 1.0 NS ON A 1 GHZ REMARK 220 LINUX PC. FRAMES WERE SAVED EVERY 1PS. DURING THE REMARK 220 SIMULATIONS THE C-TERMINAL DOMAINS ROTATED INTO A REMARK 220 DIFFERENT CONFORMATION AND FORMED A POTENTIAL BINDING REMARK 220 SITE FOR DNA. THE INITIAL MODEL FOR VIRAL DNA WAS TAKEN REMARK 220 FROM THE CRYSTAL STRUCTURE OF 1K61, WHICH CONTAINED 20 REMARK 220 BASE PAIRS OF B-DNA. THE DNA WAS CONVERTED TO THE HIV U5 REMARK 220 SEQUENCE USING AMMP TO GENERATE NEW ATOMIC POSITIONS REMARK 220 WITH AN ANALYTIC COORDINATE GENERATOR (HARRISON, 1999) REMARK 220 FOLLOWED BY CONJUGATE GRADIENTS MINIMIZATION FOR EACH REMARK 220 SUBSTITUTED BASE PAIR. THEN THE ENTIRE DNA MOLECULE WAS REMARK 220 MINIMIZED USING CONJUGATE GRADIENTS WITH ALL NON-BONDED REMARK 220 AND GEOMETRIC TERMS. THE DNA WAS POSITIONED REMARK 220 APPROXIMATELY USING THE DNA AT THE CATALYTIC SITE OF TN5 REMARK 220 TRANSPOSASE AS A GUIDE TO PLACE THE PROCESSED 3 OH AT REMARK 220 THE CATALYTIC SITE OF IN. THE TWO PROCESSED NUCLEOTIDES REMARK 220 GT WERE REMOVED FROM THE 3 END. A MAGNESIUM ION WAS REMARK 220 PLACED BETWEEN THE 3 OH, AND THE SIDE CHAINS OF ASP 64 REMARK 220 AND ASP 116 AT THE CATALYTIC SITE OF EACH SUBUNIT. THE REMARK 220 DNA WAS ROTATED AND TRANSLATED INTO THE GROOVE FORMED REMARK 220 BETWEEN THE CATALYTIC DOMAIN OF SUBUNIT B AND N- AND C- REMARK 220 TERMINAL DOMAINS OF SUBUNIT D APPROXIMATELY USING O REMARK 220 (JONES ET AL., 1991). THE FIT TO IN WAS OPTIMIZED USING REMARK 220 THE GDOCK ROUTINE OF AMMP WITH HARMONIC RESTRAINTS TO REMARK 220 ATOMIC POSITIONS FOR CRITICAL ATOMS (TETHERS) AND REMARK 220 RESTRAINTS ON THE DNA INTERATOMIC DISTANCES, FOLLOWED BY REMARK 220 CONJUGATE GRADIENTS MINIMIZATION. THE GDOCK ROUTINE USES REMARK 220 A GENETIC ALGORITHM TO SEARCH ROTATIONAL AND REMARK 220 TRANSLATIONAL SPACE WHERE THE ROTATIONAL COMPONENTS ARE REMARK 220 REPRESENTED WITH UNIT QUATERNIONS. THE USE OF UNIT REMARK 220 QUATERNIONS INSTEAD OF ORTHOGONAL ROTATION MATRICES REMARK 220 AVOIDS ARTIFICIAL SINGULARITIES IN THE SEARCH SPACE AND REMARK 220 GREATLY ENHANCES THE CONVERGENCE OF THE ALGORITHM. THE REMARK 220 TWO UNPAIRED NUCLEOTIDES 1-2 WERE MOVED OUT OF THE B- REMARK 220 FORM USING TORSION SEARCHES TO ELIMINATE COLLISION WITH REMARK 220 THE PROTEIN. THE 3 OH WAS RESTRAINED TO COORDINATE WITH REMARK 220 THE MG ION AT THE CATALYTIC SITE. ONCE THE FIRST DNA WAS REMARK 220 PLACED IN THE GROOVE, THE SECOND LTR END WAS PLACED BY REMARK 220 SYMMETRY BETWEEN THE CATALYTIC DOMAINS OF SUBUNIT D AND REMARK 220 THE N- AND C-TERMINAL DOMAINS OF SUBUNIT B, FOLLOWED BY REMARK 220 ALTERNATING RIGID BODY MOVEMENTS OF THE LTR AND C- REMARK 220 TERMINAL DOMAIN USING GDOCK TO OVERCOME COLLISIONS SINCE REMARK 220 THE TETRAMER MODEL IS NOT COMPLETELY SYMMETRIC. FINALLY, REMARK 220 THE COMPLEX WAS MINIMIZED BY CONJUGATE GRADIENTS TO REMARK 220 ENSURE GOOD NON-BONDED INTERACTIONS. HARRISON, R. W. REMARK 220 (1993) J. COMP. CHEM. 14:1112-1122. WEBER, I. T. AND REMARK 220 HARRISON, R. W. (1996) PROTEIN ENG. 9:679-690. WEBER, I. REMARK 220 T. AND HARRISON, R. W. (1997) PROTEIN SCI. 11:2365-2374. REMARK 220 BAGOSSI, P., ZAHUCZKY, G., TOZSER, J., WEBER, I. T. AND REMARK 220 HARRISON, R. W. (1999) J. MOL. MODEL 5: 143-152. REMARK 220 HARRISON, R. W. (1999) J. MATH.CHEM. 26:125-137. JONES, REMARK 220 T. A., ZOU, J. Y., COWAN, S. W., AND KJELDGAARD, M. REMARK 220 (1991) ACTA CRYST. A47: 110-119. REMARK 225 REMARK 225 THEORETICAL MODEL REMARK 225 THE COORDINATES IN THIS ENTRY REPRESENT A MODEL STRUCTURE. REMARK 225 PROTEIN DATA BANK CONVENTIONS REQUIRE THAT CRYST1 AND REMARK 225 SCALE RECORDS BE INCLUDED, BUT THE VALUES ON THESE REMARK 225 RECORDS ARE MEANINGLESS. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A -11 REMARK 465 LYS A -10 REMARK 465 LEU A -9 REMARK 465 VAL A -8 REMARK 465 SER A -7 REMARK 465 ALA A -6 REMARK 465 GLY A -5 REMARK 465 ILE A -4 REMARK 465 ARG A -3 REMARK 465 LYS A -2 REMARK 465 ILE A -1 REMARK 465 LEU A 0 REMARK 465 ASP B 289 REMARK 465 LYS B 290 REMARK 465 LEU B 291 REMARK 465 VAL B 292 REMARK 465 SER B 293 REMARK 465 ALA B 294 REMARK 465 GLY B 295 REMARK 465 ILE B 296 REMARK 465 ARG B 297 REMARK 465 LYS B 298 REMARK 465 ILE B 299 REMARK 465 LEU B 300 REMARK 465 ASP C 589 REMARK 465 LYS C 590 REMARK 465 LEU C 591 REMARK 465 VAL C 592 REMARK 465 SER C 593 REMARK 465 ALA C 594 REMARK 465 GLY C 595 REMARK 465 ILE C 596 REMARK 465 ARG C 597 REMARK 465 LYS C 598 REMARK 465 ILE C 599 REMARK 465 LEU C 600 REMARK 465 ASP D 889 REMARK 465 LYS D 890 REMARK 465 LEU D 891 REMARK 465 VAL D 892 REMARK 465 SER D 893 REMARK 465 ALA D 894 REMARK 465 GLY D 895 REMARK 465 ILE D 896 REMARK 465 ARG D 897 REMARK 465 LYS D 898 REMARK 465 ILE D 899 REMARK 465 LEU D 900 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI REMARK 500 O2P A H 2121 K K H 1452 2.05 REMARK 500 OD1 ASP A 55 K K A 1451 2.10 REMARK 500 OD2 ASP A 55 K K A 1451 2.17 REMARK 500 OE1 GLN A 148 K K A 1451 2.17 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),F6.3) REMARK 500 REMARK 500 EXPECTED VALUES: ENGH AND HUBER, 1991 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ASP D 964 CA ASP D 964 CB 0.260 REMARK 500 ASP D 964 CB ASP D 964 CG 0.264 REMARK 500 ASP D 964 CG ASP D 964 OD1 0.209 REMARK 500 ASP D1016 CA ASP D1016 CB 0.286 REMARK 500 ASP D1016 CB ASP D1016 CG 0.242 REMARK 500 ASP D1016 CG ASP D1016 OD1 0.211 REMARK 500 ASP D1129 CG ASP D1129 OD2 0.613 REMARK 500 SER D1130 CA SER D1130 CB 0.621 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES: ENGH AND HUBER, 1991 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP B 416 CA - CB - CG ANGL. DEV. = 24.1 DEGREES REMARK 500 ASN B 444 CA - CB - CG ANGL. DEV. = 24.1 DEGREES REMARK 500 GLN B 516 N - CA - CB ANGL. DEV. = 23.4 DEGREES REMARK 500 ILE B 517 N - CA - CB ANGL. DEV. = 25.8 DEGREES REMARK 500 ASP D 964 CA - CB - CG ANGL. DEV. = 29.1 DEGREES REMARK 500 ASP D1016 N - CA - CB ANGL. DEV. = 25.9 DEGREES REMARK 500 ASP D1016 CA - CB - CG ANGL. DEV. = 33.9 DEGREES REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 3 -67.44 62.19 REMARK 500 GLU A 69 -64.14 70.26 REMARK 500 GLN A 221 -66.50 70.09 REMARK 500 ASP B 341 -77.32 61.54 REMARK 500 GLU B 369 -68.60 64.65 REMARK 500 ASP B 416 -65.72 35.91 REMARK 500 ILE B 441 -66.52 66.33 REMARK 500 GLN B 446 68.79 -13.33 REMARK 500 SER B 447 109.63 141.10 REMARK 500 GLN B 448 -53.46 127.70 REMARK 500 ASP C 603 -57.85 63.86 REMARK 500 GLN C 653 -112.73 59.22 REMARK 500 GLN C 821 -113.18 47.43 REMARK 500 ARG C 869 -67.33 67.16 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLN A 148 GLY A 149 30.99 REMARK 500 PHE A 223 ARG A 224 -143.59 REMARK 500 ILE A 251 GLN A 252 147.04 REMARK 500 GLU B 311 HIS B 312 147.19 REMARK 500 GLU B 313 LYS B 314 141.62 REMARK 500 LYS B 346 GLY B 347 -57.50 REMARK 500 GLY B 347 GLU B 348 39.81 REMARK 500 ASP B 355 CYS B 356 40.95 REMARK 500 GLU B 369 GLY B 370 -141.11 REMARK 500 ASP B 416 ASN B 417 -136.25 REMARK 500 ASN B 417 GLY B 418 -140.84 REMARK 500 ILE B 435 LYS B 436 148.58 REMARK 500 ASP B 439 GLY B 440 -147.84 REMARK 500 PRO B 442 TYR B 443 112.90 REMARK 500 TYR B 443 ASN B 444 81.57 REMARK 500 ASN B 444 PRO B 445 -123.96 REMARK 500 PRO B 445 GLN B 446 -125.70 REMARK 500 SER B 447 GLN B 448 -107.67 REMARK 500 GLN B 509 THR B 510 -144.81 REMARK 500 LYS B 564 ALA B 565 -143.26 REMARK 500 GLY C 647 GLU C 648 40.42 REMARK 500 GLU C 648 ALA C 649 -34.15 REMARK 500 ASP C 655 CYS C 656 30.87 REMARK 500 GLN C 737 GLU C 738 -148.15 REMARK 500 GLY C 789 GLY C 790 -145.27 REMARK 500 LYS D 934 GLU D 935 -147.96 REMARK 500 LYS D 942 CYS D 943 -140.77 REMARK 500 LEU D 945 LYS D 946 -149.82 REMARK 500 LEU D 963 ASP D 964 148.14 REMARK 500 CYS D 965 THR D 966 -143.49 REMARK 500 ASP D 1016 ASN D 1017 -144.91 REMARK 500 GLN D 1037 GLU D 1038 -149.28 REMARK 500 ASN D 1044 PRO D 1045 143.93 REMARK 500 SER D 1047 GLN D 1048 120.94 REMARK 500 GLU D 1052 SER D 1053 -148.85 REMARK 500 ASN D 1055 LYS D 1056 67.73 REMARK 500 LYS D 1056 GLU D 1057 -146.57 REMARK 500 TYR D 1127 ARG D 1128 117.98 REMARK 500 ARG D 1128 ASP D 1129 132.83 REMARK 500 ASP D 1129 SER D 1130 -138.94 REMARK 500 ASN D 1132 SER D 1133 -145.03 REMARK 500 LYS D 1164 ALA D 1165 -146.81 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1K6Y RELATED DB: PDB REMARK 900 THE N-TERMINAL DOMAIN AND CATALYTIC CORE OF HIV-1 INTEGRASE REMARK 900 RELATED ID: 1EX4 RELATED DB: PDB REMARK 900 THE CATALYTIC CORE AND C-TERMINAL DOMAIN OF HIV-1 INTEGRASE REMARK 900 RELATED ID: 1K61 RELATED DB: PDB REMARK 900 THE INITIAL MODEL FOR VIRAL B-DNA DBREF 2G3L A -11 270 UNP P04587 POL_HV1B5 1147 1428 DBREF 2G3L B 289 570 UNP P04587 POL_HV1B5 1147 1428 DBREF 2G3L C 589 870 UNP P04587 POL_HV1B5 1147 1428 DBREF 2G3L D 889 1170 UNP P04587 POL_HV1B5 1147 1428 SEQADV 2G3L VAL A 125 UNP P04587 ILE 1271 CONFLICT SEQADV 2G3L THR A 136 UNP P04587 ALA 1282 CONFLICT SEQADV 2G3L ASP A 143 UNP P04587 TRP 1289 CONFLICT SEQADV 2G3L ASP A 151 UNP P04587 PHE 1297 CONFLICT SEQADV 2G3L ILE A 163 UNP P04587 VAL 1309 CONFLICT SEQADV 2G3L LYS A 197 UNP P04587 PHE 1343 CONFLICT SEQADV 2G3L SER A 245 UNP P04587 PRO 1391 CONFLICT SEQADV 2G3L VAL B 425 UNP P04587 ILE 1271 CONFLICT SEQADV 2G3L THR B 436 UNP P04587 ALA 1282 CONFLICT SEQADV 2G3L ASP B 443 UNP P04587 TRP 1289 CONFLICT SEQADV 2G3L ASP B 451 UNP P04587 PHE 1297 CONFLICT SEQADV 2G3L ILE B 463 UNP P04587 VAL 1309 CONFLICT SEQADV 2G3L LYS B 497 UNP P04587 PHE 1343 CONFLICT SEQADV 2G3L SER B 545 UNP P04587 PRO 1391 CONFLICT SEQADV 2G3L VAL C 725 UNP P04587 ILE 1271 CONFLICT SEQADV 2G3L THR C 736 UNP P04587 ALA 1282 CONFLICT SEQADV 2G3L ASP C 743 UNP P04587 TRP 1289 CONFLICT SEQADV 2G3L ASP C 751 UNP P04587 PHE 1297 CONFLICT SEQADV 2G3L ILE C 763 UNP P04587 VAL 1309 CONFLICT SEQADV 2G3L LYS C 797 UNP P04587 PHE 1343 CONFLICT SEQADV 2G3L SER C 745 UNP P04587 PRO 1391 CONFLICT SEQADV 2G3L VAL D 1025 UNP P04587 ILE 1271 CONFLICT SEQADV 2G3L THR D 1036 UNP P04587 ALA 1282 CONFLICT SEQADV 2G3L ASP D 1043 UNP P04587 TRP 1289 CONFLICT SEQADV 2G3L ASP D 1051 UNP P04587 PHE 1297 CONFLICT SEQADV 2G3L ILE D 1063 UNP P04587 VAL 1309 CONFLICT SEQADV 2G3L LYS D 1097 UNP P04587 PHE 1343 CONFLICT SEQADV 2G3L SER D 1145 UNP P04587 PRO 1391 CONFLICT SEQRES 1 A 282 ASP LYS LEU VAL SER ALA GLY ILE ARG LYS ILE LEU PHE SEQRES 2 A 282 LEU ASP GLY ILE ASP LYS ALA GLN GLU GLU HIS GLU LYS SEQRES 3 A 282 TYR HIS SER ASN TRP ARG ALA MET ALA SER ASP PHE ASN SEQRES 4 A 282 LEU PRO PRO VAL VAL ALA LYS GLU ILE VAL ALA SER CYS SEQRES 5 A 282 ASP LYS CYS GLN LEU LYS GLY GLU ALA MET HIS GLY GLN SEQRES 6 A 282 VAL ASP CYS SER PRO GLY ILE TRP GLN LEU ASP CYS THR SEQRES 7 A 282 HIS LEU GLU GLY LYS VAL ILE LEU VAL ALA VAL HIS VAL SEQRES 8 A 282 ALA SER GLY TYR ILE GLU ALA GLU VAL ILE PRO ALA GLU SEQRES 9 A 282 THR GLY GLN GLU THR ALA TYR PHE LEU LEU LYS LEU ALA SEQRES 10 A 282 GLY ARG TRP PRO VAL LYS THR VAL HIS THR ASP ASN GLY SEQRES 11 A 282 SER ASN PHE THR SER THR THR VAL LYS ALA ALA CYS ASP SEQRES 12 A 282 TRP ALA GLY ILE LYS GLN GLU ASP GLY ILE PRO TYR ASN SEQRES 13 A 282 PRO GLN SER GLN GLY VAL ILE GLU SER MET ASN LYS GLU SEQRES 14 A 282 LEU LYS LYS ILE ILE GLY GLN VAL ARG ASP GLN ALA GLU SEQRES 15 A 282 HIS LEU LYS THR ALA VAL GLN MET ALA VAL PHE ILE HIS SEQRES 16 A 282 ASN LYS LYS ARG LYS GLY GLY ILE GLY GLY TYR SER ALA SEQRES 17 A 282 GLY GLU ARG ILE VAL ASP ILE ILE ALA THR ASP ILE GLN SEQRES 18 A 282 THR LYS GLU LEU GLN LYS GLN ILE THR LYS ILE GLN ASN SEQRES 19 A 282 PHE ARG VAL TYR TYR ARG ASP SER ARG ASN SER LEU TRP SEQRES 20 A 282 LYS GLY PRO ALA LYS LEU LEU TRP LYS GLY GLU GLY ALA SEQRES 21 A 282 VAL VAL ILE GLN ASP ASN SER ASP ILE LYS VAL VAL PRO SEQRES 22 A 282 ARG ARG LYS ALA LYS ILE ILE ARG ASP SEQRES 1 B 282 ASP LYS LEU VAL SER ALA GLY ILE ARG LYS ILE LEU PHE SEQRES 2 B 282 LEU ASP GLY ILE ASP LYS ALA GLN GLU GLU HIS GLU LYS SEQRES 3 B 282 TYR HIS SER ASN TRP ARG ALA MET ALA SER ASP PHE ASN SEQRES 4 B 282 LEU PRO PRO VAL VAL ALA LYS GLU ILE VAL ALA SER CYS SEQRES 5 B 282 ASP LYS CYS GLN LEU LYS GLY GLU ALA MET HIS GLY GLN SEQRES 6 B 282 VAL ASP CYS SER PRO GLY ILE TRP GLN LEU ASP CYS THR SEQRES 7 B 282 HIS LEU GLU GLY LYS VAL ILE LEU VAL ALA VAL HIS VAL SEQRES 8 B 282 ALA SER GLY TYR ILE GLU ALA GLU VAL ILE PRO ALA GLU SEQRES 9 B 282 THR GLY GLN GLU THR ALA TYR PHE LEU LEU LYS LEU ALA SEQRES 10 B 282 GLY ARG TRP PRO VAL LYS THR VAL HIS THR ASP ASN GLY SEQRES 11 B 282 SER ASN PHE THR SER THR THR VAL LYS ALA ALA CYS ASP SEQRES 12 B 282 TRP ALA GLY ILE LYS GLN GLU ASP GLY ILE PRO TYR ASN SEQRES 13 B 282 PRO GLN SER GLN GLY VAL ILE GLU SER MET ASN LYS GLU SEQRES 14 B 282 LEU LYS LYS ILE ILE GLY GLN VAL ARG ASP GLN ALA GLU SEQRES 15 B 282 HIS LEU LYS THR ALA VAL GLN MET ALA VAL PHE ILE HIS SEQRES 16 B 282 ASN LYS LYS ARG LYS GLY GLY ILE GLY GLY TYR SER ALA SEQRES 17 B 282 GLY GLU ARG ILE VAL ASP ILE ILE ALA THR ASP ILE GLN SEQRES 18 B 282 THR LYS GLU LEU GLN LYS GLN ILE THR LYS ILE GLN ASN SEQRES 19 B 282 PHE ARG VAL TYR TYR ARG ASP SER ARG ASN SER LEU TRP SEQRES 20 B 282 LYS GLY PRO ALA LYS LEU LEU TRP LYS GLY GLU GLY ALA SEQRES 21 B 282 VAL VAL ILE GLN ASP ASN SER ASP ILE LYS VAL VAL PRO SEQRES 22 B 282 ARG ARG LYS ALA LYS ILE ILE ARG ASP SEQRES 1 C 282 ASP LYS LEU VAL SER ALA GLY ILE ARG LYS ILE LEU PHE SEQRES 2 C 282 LEU ASP GLY ILE ASP LYS ALA GLN GLU GLU HIS GLU LYS SEQRES 3 C 282 TYR HIS SER ASN TRP ARG ALA MET ALA SER ASP PHE ASN SEQRES 4 C 282 LEU PRO PRO VAL VAL ALA LYS GLU ILE VAL ALA SER CYS SEQRES 5 C 282 ASP LYS CYS GLN LEU LYS GLY GLU ALA MET HIS GLY GLN SEQRES 6 C 282 VAL ASP CYS SER PRO GLY ILE TRP GLN LEU ASP CYS THR SEQRES 7 C 282 HIS LEU GLU GLY LYS VAL ILE LEU VAL ALA VAL HIS VAL SEQRES 8 C 282 ALA SER GLY TYR ILE GLU ALA GLU VAL ILE PRO ALA GLU SEQRES 9 C 282 THR GLY GLN GLU THR ALA TYR PHE LEU LEU LYS LEU ALA SEQRES 10 C 282 GLY ARG TRP PRO VAL LYS THR VAL HIS THR ASP ASN GLY SEQRES 11 C 282 SER ASN PHE THR SER THR THR VAL LYS ALA ALA CYS ASP SEQRES 12 C 282 TRP ALA GLY ILE LYS GLN GLU ASP GLY ILE PRO TYR ASN SEQRES 13 C 282 PRO GLN SER GLN GLY VAL ILE GLU SER MET ASN LYS GLU SEQRES 14 C 282 LEU LYS LYS ILE ILE GLY GLN VAL ARG ASP GLN ALA GLU SEQRES 15 C 282 HIS LEU LYS THR ALA VAL GLN MET ALA VAL PHE ILE HIS SEQRES 16 C 282 ASN LYS LYS ARG LYS GLY GLY ILE GLY GLY TYR SER ALA SEQRES 17 C 282 GLY GLU ARG ILE VAL ASP ILE ILE ALA THR ASP ILE GLN SEQRES 18 C 282 THR LYS GLU LEU GLN LYS GLN ILE THR LYS ILE GLN ASN SEQRES 19 C 282 PHE ARG VAL TYR TYR ARG ASP SER ARG ASN SER LEU TRP SEQRES 20 C 282 LYS GLY PRO ALA LYS LEU LEU TRP LYS GLY GLU GLY ALA SEQRES 21 C 282 VAL VAL ILE GLN ASP ASN SER ASP ILE LYS VAL VAL PRO SEQRES 22 C 282 ARG ARG LYS ALA LYS ILE ILE ARG ASP SEQRES 1 D 282 ASP LYS LEU VAL SER ALA GLY ILE ARG LYS ILE LEU PHE SEQRES 2 D 282 LEU ASP GLY ILE ASP LYS ALA GLN GLU GLU HIS GLU LYS SEQRES 3 D 282 TYR HIS SER ASN TRP ARG ALA MET ALA SER ASP PHE ASN SEQRES 4 D 282 LEU PRO PRO VAL VAL ALA LYS GLU ILE VAL ALA SER CYS SEQRES 5 D 282 ASP LYS CYS GLN LEU LYS GLY GLU ALA MET HIS GLY GLN SEQRES 6 D 282 VAL ASP CYS SER PRO GLY ILE TRP GLN LEU ASP CYS THR SEQRES 7 D 282 HIS LEU GLU GLY LYS VAL ILE LEU VAL ALA VAL HIS VAL SEQRES 8 D 282 ALA SER GLY TYR ILE GLU ALA GLU VAL ILE PRO ALA GLU SEQRES 9 D 282 THR GLY GLN GLU THR ALA TYR PHE LEU LEU LYS LEU ALA SEQRES 10 D 282 GLY ARG TRP PRO VAL LYS THR VAL HIS THR ASP ASN GLY SEQRES 11 D 282 SER ASN PHE THR SER THR THR VAL LYS ALA ALA CYS ASP SEQRES 12 D 282 TRP ALA GLY ILE LYS GLN GLU ASP GLY ILE PRO TYR ASN SEQRES 13 D 282 PRO GLN SER GLN GLY VAL ILE GLU SER MET ASN LYS GLU SEQRES 14 D 282 LEU LYS LYS ILE ILE GLY GLN VAL ARG ASP GLN ALA GLU SEQRES 15 D 282 HIS LEU LYS THR ALA VAL GLN MET ALA VAL PHE ILE HIS SEQRES 16 D 282 ASN LYS LYS ARG LYS GLY GLY ILE GLY GLY TYR SER ALA SEQRES 17 D 282 GLY GLU ARG ILE VAL ASP ILE ILE ALA THR ASP ILE GLN SEQRES 18 D 282 THR LYS GLU LEU GLN LYS GLN ILE THR LYS ILE GLN ASN SEQRES 19 D 282 PHE ARG VAL TYR TYR ARG ASP SER ARG ASN SER LEU TRP SEQRES 20 D 282 LYS GLY PRO ALA LYS LEU LEU TRP LYS GLY GLU GLY ALA SEQRES 21 D 282 VAL VAL ILE GLN ASP ASN SER ASP ILE LYS VAL VAL PRO SEQRES 22 D 282 ARG ARG LYS ALA LYS ILE ILE ARG ASP SEQRES 1 E 18 T G T G G A A A A T C T C SEQRES 2 E 18 T A G C A SEQRES 1 F 20 A C T G C T A G A G A T T SEQRES 2 F 20 T T C C A C A SEQRES 1 G 18 T G T G G A A A A T C T C SEQRES 2 G 18 T A G C A SEQRES 1 H 20 A C T G C T A G A G A T T SEQRES 2 H 20 T T C C A C A HET ZN 1401 1 HET ZN 1402 1 HET ZN 1403 1 HET ZN 1404 1 HET K A1451 1 HET K H1452 1 HET K 1453 1 HET K 1454 1 HET MG 1551 1 HET MG 1552 1 HET MG 1553 1 HET MG 1554 1 HETNAM ZN ZINC ION HETNAM K POTASSIUM ION HETNAM MG MAGNESIUM ION FORMUL 9 ZN 4(ZN 2+) FORMUL 13 K 4(K 1+) FORMUL 17 MG 4(MG 2+) HELIX 1 1 ILE A 5 GLU A 11 1 7 HELIX 2 2 TRP A 19 ALA A 21 5 3 HELIX 3 3 MET A 22 ASN A 27 1 6 HELIX 4 4 PRO A 29 CYS A 40 1 12 HELIX 5 5 ALA A 80 GLY A 82 5 3 HELIX 6 6 THR A 93 TRP A 108 1 16 HELIX 7 7 SER A 123 GLY A 134 1 12 HELIX 8 8 VAL A 150 ARG A 166 1 17 HELIX 9 9 HIS A 171 LYS A 185 1 15 HELIX 10 10 SER A 195 LEU A 213 1 19 HELIX 11 11 GLN A 216 GLN A 221 1 6 HELIX 12 12 ASN B 318 ASP B 325 1 8 HELIX 13 13 PRO B 329 SER B 339 1 11 HELIX 14 14 GLY B 394 GLY B 406 1 13 HELIX 15 15 SER B 423 GLY B 434 1 12 HELIX 16 16 GLY B 449 SER B 453 5 5 HELIX 17 17 MET B 454 ARG B 466 1 13 HELIX 18 18 THR B 474 ARG B 487 1 14 HELIX 19 19 SER B 495 GLN B 509 1 15 HELIX 20 20 THR B 510 GLN B 521 1 12 HELIX 21 21 ASP C 603 TYR C 615 1 13 HELIX 22 22 ASN C 618 PHE C 626 1 9 HELIX 23 23 PRO C 630 CYS C 640 1 11 HELIX 24 24 THR C 693 GLY C 706 1 14 HELIX 25 25 GLY C 718 SER C 723 1 6 HELIX 26 26 SER C 723 ALA C 733 1 11 HELIX 27 27 GLY C 749 VAL C 765 1 17 HELIX 28 28 HIS C 771 LYS C 785 1 15 HELIX 29 29 SER C 795 THR C 818 1 24 HELIX 30 30 GLY D 904 ALA D 908 5 5 HELIX 31 31 GLN D 909 HIS D 916 1 8 HELIX 32 32 ASN D 918 PHE D 926 1 9 HELIX 33 33 PRO D 929 SER D 939 1 11 HELIX 34 34 ALA D 980 GLY D 982 5 3 HELIX 35 35 THR D 993 ALA D 1005 1 13 HELIX 36 36 GLY D 1018 THR D 1022 5 5 HELIX 37 37 SER D 1023 GLY D 1034 1 12 HELIX 38 38 GLU D 1057 ALA D 1069 1 13 HELIX 39 39 HIS D 1071 ARG D 1087 1 17 HELIX 40 40 SER D 1095 THR D 1118 1 24 SHEET 1 A 3 TRP A 61 HIS A 67 0 SHEET 2 A 3 VAL A 72 HIS A 78 -1 O ILE A 73 N THR A 66 SHEET 3 A 3 ILE A 84 VAL A 88 -1 O GLU A 85 N ALA A 76 SHEET 1 B 5 ILE A 257 VAL A 259 0 SHEET 2 B 5 VAL A 249 GLN A 252 -1 N ILE A 251 O LYS A 258 SHEET 3 B 5 LYS A 236 LYS A 244 -1 N TRP A 243 O VAL A 250 SHEET 4 B 5 VAL A 225 TYR A 227 -1 N VAL A 225 O ALA A 239 SHEET 5 B 5 ALA A 265 ILE A 267 -1 O LYS A 266 N TYR A 226 SHEET 1 C 4 ILE B 384 ILE B 389 0 SHEET 2 C 4 VAL B 372 HIS B 378 -1 N ALA B 376 O GLU B 385 SHEET 3 C 4 ILE B 360 ASP B 364 -1 N GLN B 362 O VAL B 377 SHEET 4 C 4 THR B 412 HIS B 414 1 O HIS B 414 N TRP B 361 SHEET 1 D 5 ILE B 557 PRO B 561 0 SHEET 2 D 5 ALA B 548 GLN B 552 -1 N ILE B 551 O LYS B 558 SHEET 3 D 5 LYS B 536 LYS B 544 -1 N LYS B 540 O GLN B 552 SHEET 4 D 5 ARG B 524 TYR B 527 -1 N VAL B 525 O ALA B 539 SHEET 5 D 5 ALA B 565 ILE B 567 -1 O LYS B 566 N TYR B 526 SHEET 1 E 4 TYR C 683 GLU C 685 0 SHEET 2 E 4 LYS C 671 HIS C 678 -1 N ALA C 676 O GLU C 685 SHEET 3 E 4 ILE C 660 LEU C 668 -1 N THR C 666 O ILE C 673 SHEET 4 E 4 THR C 712 VAL C 713 1 O THR C 712 N TRP C 661 SHEET 1 F 2 TYR C 826 TYR C 827 0 SHEET 2 F 2 ALA C 865 LYS C 866 -1 O LYS C 866 N TYR C 826 SHEET 1 G 2 ALA C 848 GLN C 852 0 SHEET 2 G 2 ILE C 857 PRO C 861 -1 O VAL C 860 N VAL C 849 SHEET 1 H 4 VAL D 977 HIS D 978 0 SHEET 2 H 4 TRP D 961 LEU D 963 -1 N GLN D 962 O VAL D 977 SHEET 3 H 4 THR D1012 THR D1015 1 O HIS D1014 N LEU D 963 SHEET 4 H 4 LYS D1036 GLN D1037 1 O LYS D1036 N VAL D1013 SHEET 1 I 3 CYS D 965 THR D 966 0 SHEET 2 I 3 ILE D 973 LEU D 974 -1 O ILE D 973 N THR D 966 SHEET 3 I 3 GLU D 987 VAL D 988 -1 O GLU D 987 N LEU D 974 SHEET 1 J 5 ILE D1157 PRO D1161 0 SHEET 2 J 5 ALA D1148 GLN D1152 -1 N VAL D1149 O VAL D1160 SHEET 3 J 5 LYS D1136 TRP D1143 -1 N LEU D1142 O VAL D1150 SHEET 4 J 5 ARG D1124 TYR D1127 -1 N VAL D1125 O ALA D1139 SHEET 5 J 5 LYS D1166 ILE D1168 -1 O LYS D1166 N TYR D1126 CISPEP 1 LEU A 45 LYS A 46 0 -5.76 CISPEP 2 LYS A 46 GLY A 47 0 8.81 CISPEP 3 GLU A 48 ALA A 49 0 20.20 CISPEP 4 MET A 50 HIS A 51 0 20.74 CISPEP 5 HIS A 51 GLY A 52 0 -24.33 CISPEP 6 GLY A 52 GLN A 53 0 -17.72 CISPEP 7 GLN A 53 VAL A 54 0 -6.69 CISPEP 8 VAL A 54 ASP A 55 0 1.55 CISPEP 9 GLY A 237 PRO A 238 0 5.13 CISPEP 10 ALA B 349 MET B 350 0 23.02 CISPEP 11 MET B 350 HIS B 351 0 11.24 CISPEP 12 HIS B 351 GLY B 352 0 -24.41 CISPEP 13 VAL B 354 ASP B 355 0 -22.27 CISPEP 14 GLN B 448 GLY B 449 0 21.07 CISPEP 15 GLY B 537 PRO B 538 0 4.79 CISPEP 16 HIS C 651 GLY C 652 0 5.74 CISPEP 17 GLY C 652 GLN C 653 0 -13.50 CISPEP 18 GLU C 669 GLY C 670 0 -5.52 CISPEP 19 GLY C 837 PRO C 838 0 -24.61 CISPEP 20 GLY D 947 GLU D 948 0 -4.00 CISPEP 21 GLU D 948 ALA D 949 0 18.05 CISPEP 22 GLY D 952 GLN D 953 0 4.98 CISPEP 23 GLN D 953 VAL D 954 0 11.81 CISPEP 24 VAL D 954 ASP D 955 0 -2.26 CISPEP 25 ASP D 955 CYS D 956 0 -7.20 CISPEP 26 GLU D 969 GLY D 970 0 19.30 CISPEP 27 TYR D 1043 ASN D 1044 0 16.49 CISPEP 28 GLY D 1137 PRO D 1138 0 -5.02 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MASTER 405 0 12 40 37 0 0 6 0 0 0 96 END